The CRO concept fluctuated and declined in early trading. Medicis and Yakkang Biotech fell more than 10%, and many stocks such as Baicheng Pharmaceuticals, Novizan, Betta Pharmaceuticals, Boji Pharmaceuticals, and Hongbo Pharmaceutical fell more than 6%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.